期刊文献+

乳腺浸润性导管癌免疫分型与病理特征的关系

Analysis of the Relationship between Classification and Pathological Characteristics in Breast Infiltrating Ductal Carcinoma Immune
下载PDF
导出
摘要 目的:用免疫组织化学的方法检测乳腺浸润性导管癌特定蛋白的表达并进行免疫分型,探讨不同的免疫分型与病理特征的关系。方法用 EnVision二步法检测98例乳腺浸润性导管癌ER、PR、HER-2和CK5/6,根据结果进行免疫分型。结果98例乳腺浸润性导管癌 ER、PR、HER-2和 CK5/6的阳性病例为64例、45例、24例、23例。免疫分型:管腔 A型54例、管腔 B型20例、HER-2过表达型7例、基底细胞样型9例和无法分类型8例。病理特征指标为肿块大小、组织学分级和淋巴结转移,免疫分型与组织学分级的差异具有统计学意义(P<0.05)。免疫分型与肿块大小、淋巴结转移的差异具无统计学意义(P>0.05)。结论用免疫组织化学方法对乳腺浸润性导管癌进行免疫分型,方法简便可行,对于评估预后和指导临床治疗具有一定的意义。 Objective This study try to subclassify breast cancer into dif edrnt subgroups according to immunohistochemical stain.The relationship between subtypes and pathological cariticrisetic have been disscused.Methods Nighty-eight cases of infiltrative ductal carcinoma were studied using immunohistochemical staining with the antibody panel of ER,PR,HER 2 and CK5/6.The immunological subclasify is made according to the immunohistochemical stain.and previous reports.Results The expression of ER,PR,HER-2 and CK5/6 were det ected in 65.31%,45.92%,24.49%and 23.47%.Al cases were immunoclassified into five groups,with luminal A(54 cases),luminal B(20 cases),HER-2 positive(7 cases),balal-like(9 cases)and unclassied cases(8 cases).There are statistical significant in the dif erence between immunohistochemical subtypes and histocytical groups.No statistical significant have been found between immunohistochemical subtypes and other pathological features.Conclusion Acconding to immunohistochemical stain,the infiltrative ductal carcinoma could be subclassified into five subgrtypes.There is a role in evaluating the profnosis and guiding the clinical treatment.
作者 吴建农 尤敏 赵小辉 龙卫国 李梅 付先利 WU Jian-nong;YOU Min;ZHAO Xiao-hui;LONG Wei-guo;LI Mei;FU Xian-li(The Affiliated Hospital of Jiangsu University,Zhenjiang 212000,Jiangsu,China)
出处 《医学信息(医学与计算机应用)》 2014年第29期92-93,共2页 Medical Information
基金 江苏大学2010年度临床医学科技发展基金JLY2010150.
关键词 乳腺 导管 免疫分型 Breast Carcinoma Immunophenotyping
  • 相关文献

参考文献1

二级参考文献19

  • 1于慧,胡夕春.侵袭性细胞基底样乳腺癌的生物学特征[J].中华肿瘤防治杂志,2007,14(3):234-236. 被引量:4
  • 2Sotiriou C,Neo SY,McShane LM,et al.Breast cancer classification and prognosis based on gene expression profiles from a population-based study.Proc Natl Acad Sci U S A,2003,100(18):10393-10398.
  • 3Carey LA,Perou CM,Livasy CA,et al.Race,breast cancer subtypes,and survival in the Carolina Breast Cancer Study.JAMA,2006,295(21):2492-2502.
  • 4Jacquemier J,Ginestier C,Rougemont J,et al.Protein expression profiling identifies subclasses of breast cancer and predicts prognosis.Cancer Res,2005,65(3):767-779.
  • 5Goldhirsch A,Glick JH,Gelber RD,et al.Meeting highlights:international expert consensus on the primary therapy of early breast cancer 2005.Ann Oncol,2005,16(10):1569-1583.
  • 6Hammock L,Lewis M,Phillips C,et al.Strong HER-2/neu protein overexpression by immunohistochemistry often does not predict oncogene amplification by fluorescence in situ hybridization.Hum Pathol,2003,34(10):1043-1047.
  • 7Sφrlie T,Tibshirani R,Parker J,et al.Repeated observation of breast tumor subtypes in independent gene expression data sets.Proc Nad Acad Sci U S A,2003,100(14):8418-8423.
  • 8van de Rijn M,Perou CM,Tibshirani R,et al.Expression of cytokeratins 17 and 5 identifies a group of breast carcinomas with poor clinical outcome.Am J Pathol,2002,161(6):1991-1996.
  • 9Brenton JD,Carey LA,Ahmed AA,et al.Molecular classification and molecular forecasting of breast cancer;ready for clinical application? J Clin Oncol,2005,23(29):7350-7360.
  • 10Ihemelandu CU,Naab TJ,Mezghebe HM,et al.Treatment and survival outcome for molecular breast cancer subtypes in black women.Ann Surg,2008,247(3):463-469.

共引文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部